{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:14:27Z","timestamp":1792091667569,"version":"4.4.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T00:00:00Z","timestamp":1428883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T00:00:00Z","timestamp":1428883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1038\/nchembio.1797","type":"journal-article","created":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T16:14:03Z","timestamp":1428941643000},"page":"401-408","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B"],"prefix":"10.1038","volume":"11","author":[{"given":"Malia B","family":"Potts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy I","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hung","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E","family":"Toombs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf A","family":"Brekken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D","family":"Minden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B","family":"MacMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,13]]},"reference":[{"key":"BFnchembio1797_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/np200906s","volume":"75","author":"DJ Newman","year":"2012","unstructured":"Newman, D.J. & Cragg, G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75, 311\u2013335 (2012).","journal-title":"J. Nat. Prod."},{"key":"BFnchembio1797_CR2","doi-asserted-by":"publisher","first-page":"ra90","DOI":"10.1126\/scisignal.2004657","volume":"6","author":"MB Potts","year":"2013","unstructured":"Potts, M.B. et al. Using functional signature ontology (FUSION) to identify mechanisms of action for natural products. Sci. Signal. 6, ra90 (2013).","journal-title":"Sci. Signal."},{"key":"BFnchembio1797_CR3","doi-asserted-by":"publisher","first-page":"13387","DOI":"10.1021\/ja403412y","volume":"135","author":"Y Hu","year":"2013","unstructured":"Hu, Y. et al. Discoipyrroles A-D: isolation, structure determination, and synthesis of potent migration inhibitors from Bacillus hunanensis. J. Am. Chem. Soc. 135, 13387\u201313392 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchembio1797_CR4","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1126\/science.7233187","volume":"212","author":"KL Rinehart Jr.","year":"1981","unstructured":"Rinehart, K.L. Jr. et al. Didemnins: antiviral and antitumor depsipeptides from a Caribbean tunicate. Science 212, 933\u2013935 (1981).","journal-title":"Science"},{"key":"BFnchembio1797_CR5","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1021\/ja00397a055","volume":"103","author":"KL Rinehart Jr.","year":"1981","unstructured":"Rinehart, K.L. Jr., Gloer, J.B., Cook, J.C. Jr., Mizsak, S.A. & Scahill, T.A. Structures of the didemnins, antiviral and cytotoxic depsipeptides from a Caribbean tunicate. J. Am. Chem. Soc. 103, 1857\u20131859 (1981).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchembio1797_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1039\/c2np00065b","volume":"29","author":"J Lee","year":"2012","unstructured":"Lee, J., Currano, J.N., Carroll, P.J. & Joullie, M.M. Didemnins, tamandarins and related natural products. Nat. Prod. Rep. 29, 404\u2013424 (2012).","journal-title":"Nat. Prod. Rep."},{"key":"BFnchembio1797_CR7","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.2174\/138161207782360555","volume":"13","author":"C Le Tourneau","year":"2007","unstructured":"Le Tourneau, C., Raymond, E. & Faivre, S. Aplidine: a paradigm of how to handle the activity and toxicity of a novel marine anticancer poison. Curr. Pharm. Des. 13, 3427\u20133439 (2007).","journal-title":"Curr. Pharm. Des."},{"key":"BFnchembio1797_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/med.10003","volume":"22","author":"MD Vera","year":"2002","unstructured":"Vera, M.D. & Joullie, M.M. Natural products as probes of cell biology: 20 years of didemnin research. Med. Res. Rev. 22, 102\u2013145 (2002).","journal-title":"Med. Res. Rev."},{"key":"BFnchembio1797_CR9","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1038\/onc.2010.104","volume":"29","author":"RD Fritz","year":"2010","unstructured":"Fritz, R.D., Varga, Z. & Radziwill, G. CNK1 is a novel Akt interaction partner that promotes cell proliferation through the Akt-FoxO signalling axis. Oncogene 29, 3575\u20133582 (2010).","journal-title":"Oncogene"},{"key":"BFnchembio1797_CR10","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1101\/gad.1904610","volume":"24","author":"J Lim","year":"2010","unstructured":"Lim, J., Zhou, M., Veenstra, T.D. & Morrison, D.K. The CNK1 scaffold binds cytohesins and promotes insulin pathway signaling. Genes Dev. 24, 1496\u20131506 (2010).","journal-title":"Genes Dev."},{"key":"BFnchembio1797_CR11","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1158\/0008-5472.CAN-10-3253","volume":"71","author":"S Sridharan","year":"2011","unstructured":"Sridharan, S. & Basu, A. S6 kinase 2 promotes breast cancer cell survival via Akt. Cancer Res. 71, 2590\u20132599 (2011).","journal-title":"Cancer Res."},{"key":"BFnchembio1797_CR12","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.1128\/MCB.25.13.5725-5737.2005","volume":"25","author":"K Katayama","year":"2005","unstructured":"Katayama, K., Fujita, N. & Tsuruo, T. Akt\/protein kinase B-dependent phosphorylation and inactivation of WEE1Hu promote cell cycle progression at G2\/M transition. Mol. Cell. Biol. 25, 5725\u20135737 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"BFnchembio1797_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/cbf.1740","volume":"29","author":"G Kaul","year":"2011","unstructured":"Kaul, G., Pattan, G. & Rafeequi, T. Eukaryotic elongation factor-2 (eEF2): its regulation and peptide chain elongation. Cell Biochem. Funct. 29, 227\u2013234 (2011).","journal-title":"Cell Biochem. Funct."},{"key":"BFnchembio1797_CR14","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1158\/0008-5472.CAN-07-6639","volume":"68","author":"B Kefas","year":"2008","unstructured":"Kefas, B. et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 68, 3566\u20133572 (2008).","journal-title":"Cancer Res."},{"key":"BFnchembio1797_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1039\/C0MB00230E","volume":"7","author":"ZY Li","year":"2011","unstructured":"Li, Z.Y., Na, H.M., Peng, G., Pu, J. & Liu, P. Alteration of microRNA expression correlates to fatty acid-mediated insulin resistance in mouse myoblasts. Mol. Biosyst. 7, 871\u2013877 (2011).","journal-title":"Mol. Biosyst."},{"key":"BFnchembio1797_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1476-4598-12-23","volume":"12","author":"L Creevey","year":"2013","unstructured":"Creevey, L. et al. MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1. Mol. Cancer 12, 23 (2013).","journal-title":"Mol. Cancer"},{"key":"BFnchembio1797_CR17","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/onc.2012.214","volume":"32","author":"ST Guo","year":"2013","unstructured":"Guo, S.T. et al. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene 32, 1910\u20131920 (2013).","journal-title":"Oncogene"},{"key":"BFnchembio1797_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s12032-013-0557-0","volume":"30","author":"Z He","year":"2013","unstructured":"He, Z. et al. Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor. Med. Oncol. 30, 557 (2013).","journal-title":"Med. Oncol."},{"key":"BFnchembio1797_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/cdd.2013.133","volume":"21","author":"JN Gong","year":"2014","unstructured":"Gong, J.N. et al. The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia. Cell Death Differ. 21, 100\u2013112 (2014).","journal-title":"Cell Death Differ."},{"key":"BFnchembio1797_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1182\/blood-2012-07-444729","volume":"121","author":"Y Li","year":"2013","unstructured":"Li, Y. et al. Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN\/PI3K signal pathway. Blood 121, 499\u2013509 (2013).","journal-title":"Blood"},{"key":"BFnchembio1797_CR21","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","volume":"14","author":"OJ Shah","year":"2004","unstructured":"Shah, O.J., Wang, Z. & Hunter, T. Inappropriate activation of the TSC\/Rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance, and cell survival deficiencies. Curr. Biol. 14, 1650\u20131656 (2004).","journal-title":"Curr. Biol."},{"key":"BFnchembio1797_CR22","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1074\/jbc.M412179200","volume":"280","author":"I Briaud","year":"2005","unstructured":"Briaud, I. et al. Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells. J. Biol. Chem. 280, 2282\u20132293 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio1797_CR23","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.1199498","volume":"332","author":"PP Hsu","year":"2011","unstructured":"Hsu, P.P. et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317\u20131322 (2011).","journal-title":"Science"},{"key":"BFnchembio1797_CR24","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1126\/science.1199484","volume":"332","author":"Y Yu","year":"2011","unstructured":"Yu, Y. et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322\u20131326 (2011).","journal-title":"Science"},{"key":"BFnchembio1797_CR25","doi-asserted-by":"publisher","first-page":"15411","DOI":"10.1016\/S0021-9258(17)40692-2","volume":"269","author":"CM Crews","year":"1994","unstructured":"Crews, C.M., Collins, J.L., Lane, W.S., Snapper, M.L. & Schreiber, S.L. GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1 alpha. J. Biol. Chem. 269, 15411\u201315414 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio1797_CR26","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1073\/pnas.93.9.4316","volume":"93","author":"CM Crews","year":"1996","unstructured":"Crews, C.M., Lane, W.S. & Schreiber, S.L. Didemnin binds to the protein palmitoyl thioesterase responsible for infantile neuronal ceroid lipofuscinosis. Proc. Natl. Acad. Sci. USA 93, 4316\u20134319 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio1797_CR27","doi-asserted-by":"publisher","first-page":"9177","DOI":"10.1021\/bi00028a030","volume":"34","author":"BV SirDeshpande","year":"1995","unstructured":"SirDeshpande, B.V. & Toogood, P.L. Mechanism of protein synthesis inhibition by didemnin B in vitro. Biochemistry 34, 9177\u20139184 (1995).","journal-title":"Biochemistry"},{"key":"BFnchembio1797_CR28","doi-asserted-by":"publisher","first-page":"10488","DOI":"10.1021\/bi9804479","volume":"37","author":"L Meng","year":"1998","unstructured":"Meng, L., Sin, N. & Crews, C.M. The antiproliferative agent didemnin B uncompetitively inhibits palmitoyl protein thioesterase. Biochemistry 37, 10488\u201310492 (1998).","journal-title":"Biochemistry"},{"key":"BFnchembio1797_CR29","doi-asserted-by":"publisher","first-page":"23847","DOI":"10.1074\/jbc.M002758200","volume":"275","author":"AK Das","year":"2000","unstructured":"Das, A.K. et al. Structural basis for the insensitivity of a serine enzyme (palmitoyl-protein thioesterase) to phenylmethylsulfonyl fluoride. J. Biol. Chem. 275, 23847\u201323851 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio1797_CR30","first-page":"279","volume":"2","author":"J Blenis","year":"1991","unstructured":"Blenis, J., Chung, J., Erikson, E., Alcorta, D.A. & Erikson, R.L. Distinct mechanisms for the activation of the RSK kinases\/MAP2 kinase\/pp90rsk and pp70\u2013S6 kinase signaling systems are indicated by inhibition of protein synthesis. Cell Growth Differ. 2, 279\u2013285 (1991).","journal-title":"Cell Growth Differ."},{"key":"BFnchembio1797_CR31","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1074\/jbc.M706643200","volume":"283","author":"SR Kimball","year":"2008","unstructured":"Kimball, S.R., Do, A.N., Kutzler, L., Cavener, D.R. & Jefferson, L.S. Rapid turnover of the mTOR complex 1 (mTORC1) repressor REDD1 and activation of mTORC1 signaling following inhibition of protein synthesis. J. Biol. Chem. 283, 3465\u20133475 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio1797_CR32","doi-asserted-by":"publisher","first-page":"11477","DOI":"10.1073\/pnas.91.24.11477","volume":"91","author":"N Terada","year":"1994","unstructured":"Terada, N. et al. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc. Natl. Acad. Sci. USA 91, 11477\u201311481 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio1797_CR33","doi-asserted-by":"publisher","first-page":"13566","DOI":"10.1073\/pnas.251485198","volume":"98","author":"P Gupta","year":"2001","unstructured":"Gupta, P. et al. Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc. Natl. Acad. Sci. USA 98, 13566\u201313571 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio1797_CR34","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/jmg.36.6.471","volume":"36","author":"YV Voznyi","year":"1999","unstructured":"Voznyi, Y.V. et al. A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variants. J. Med. Genet. 36, 471\u2013474 (1999).","journal-title":"J. Med. Genet."},{"key":"BFnchembio1797_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6","volume":"87","author":"A Pajic","year":"2000","unstructured":"Pajic, A. et al. Cell cycle activation by c-myc in a Burkitt lymphoma model cell line. Int. J. Cancer 87, 787\u2013793 (2000).","journal-title":"Int. J. Cancer"},{"key":"BFnchembio1797_CR36","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1006\/bbrc.1995.2580","volume":"215","author":"DR Grubb","year":"1995","unstructured":"Grubb, D.R., Wolvetang, E.J. & Lawen, A. Didemnin B induces cell death by apoptosis: the fastest induction of apoptosis ever described. Biochem. Biophys. Res. Commun. 215, 1130\u20131136 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnchembio1797_CR37","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/298679a0","volume":"298","author":"S Collins","year":"1982","unstructured":"Collins, S. & Groudine, M. Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature 298, 679\u2013681 (1982).","journal-title":"Nature"},{"key":"BFnchembio1797_CR38","doi-asserted-by":"publisher","first-page":"16224","DOI":"10.1073\/pnas.0808041105","volume":"105","author":"RJ Leary","year":"2008","unstructured":"Leary, R.J. et al. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc. Natl. Acad. Sci. USA 105, 16224\u201316229 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio1797_CR39","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"BFnchembio1797_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou, H. & Hastie, T. Regularization and variable selection via the elastic net. J. R. Stat. Soc., B 67, 301\u2013320 (2005).","journal-title":"J. R. Stat. Soc., B"},{"key":"BFnchembio1797_CR41","first-page":"695","volume":"55","author":"M Savukoski","year":"1994","unstructured":"Savukoski, M. et al. Defined chromosomal assignment of CLN5 demonstrates that at least four genetic loci are involved in the pathogenesis of human ceroid lipofuscinoses. Am. J. Hum. Genet. 55, 695\u2013701 (1994).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnchembio1797_CR42","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1128\/MCB.06726-11","volume":"32","author":"A Mamo","year":"2012","unstructured":"Mamo, A., Jules, F., Dumaresq-Doiron, K., Costantino, S. & Lefrancois, S. The role of ceroid lipofuscinosis neuronal protein 5 (CLN5) in endosomal sorting. Mol. Cell. Biol. 32, 1855\u20131866 (2012).","journal-title":"Mol. Cell. Biol."},{"key":"BFnchembio1797_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1745-6150-8-29","volume":"8","author":"DC Soares","year":"2013","unstructured":"Soares, D.C. & Abbott, C.M. Highly homologous eEF1A1 and eEF1A2 exhibit differential post-translational modification with significant enrichment around localised sites of sequence variation. Biol. Direct 8, 29 (2013).","journal-title":"Biol. Direct"},{"key":"BFnchembio1797_CR44","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.gde.2011.03.007","volume":"21","author":"CR Stumpf","year":"2011","unstructured":"Stumpf, C.R. & Ruggero, D. The cancerous translation apparatus. Curr. Opin. Genet. Dev. 21, 474\u2013483 (2011).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"BFnchembio1797_CR45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3324\/haematol.2012.069757","volume":"98","author":"V Ribrag","year":"2013","unstructured":"Ribrag, V. et al. Multicenter phase II study of plitidepsin in patients with relapsed\/refractory non-Hodgkin\u2032s lymphoma. Haematologica 98, 357\u2013363 (2013).","journal-title":"Haematologica"},{"key":"BFnchembio1797_CR46","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.1158\/1078-0432.CCR-14-0259","volume":"20","author":"S Suryani","year":"2014","unstructured":"Suryani, S. et al. Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts. Clin. Cancer Res. 20, 4520\u20134531 (2014).","journal-title":"Clin. Cancer Res."},{"key":"BFnchembio1797_CR47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pharmthera.2014.08.003","volume":"145","author":"J Belmar","year":"2015","unstructured":"Belmar, J. & Fesik, S.W. Small molecule Mcl-1 inhibitors for the treatment of cancer. Pharmacol. Ther. 145, 76\u201384 (2015).","journal-title":"Pharmacol. Ther."},{"key":"BFnchembio1797_CR48","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1038\/nm.2580","volume":"17","author":"DR Robinson","year":"2011","unstructured":"Robinson, D.R. et al. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat. Med. 17, 1646\u20131651 (2011).","journal-title":"Nat. Med."},{"key":"BFnchembio1797_CR49","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L","volume":"78","author":"AF Gazdar","year":"1998","unstructured":"Gazdar, A.F. et al. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int. J. Cancer 78, 766\u2013774 (1998).","journal-title":"Int. J. Cancer"},{"key":"BFnchembio1797_CR50","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/jnci\/58.6.1795","volume":"58","author":"AJ Hackett","year":"1977","unstructured":"Hackett, A.J. et al. Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J. Natl. Cancer Inst. 58, 1795\u20131806 (1977).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFnchembio1797_CR51","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1126\/science.1133427","volume":"314","author":"T Sj\u00f6blom","year":"2006","unstructured":"Sj\u00f6blom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268\u2013274 (2006).","journal-title":"Science"},{"key":"BFnchembio1797_CR52","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/jnci\/djq279","volume":"102","author":"AF Gazdar","year":"2010","unstructured":"Gazdar, A.F., Girard, L., Lockwood, W.W., Lam, W.L. & Minna, J.D. Lung cancer cell lines as tools for biomedical discovery and research. J. Natl. Cancer Inst. 102, 1310\u20131321 (2010).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFnchembio1797_CR53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4161\/auto.5338","volume":"4","author":"DJ Klionsky","year":"2008","unstructured":"Klionsky, D.J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4, 151\u2013175 (2008).","journal-title":"Autophagy"},{"key":"BFnchembio1797_CR54","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1021\/np200543z","volume":"74","author":"M Tsukimoto","year":"2011","unstructured":"Tsukimoto, M. et al. Bacterial production of the tunicate-derived antitumor cyclic depsipeptide didemnin B. J. Nat. Prod. 74, 2329\u20132331 (2011).","journal-title":"J. Nat. Prod."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nchembio.1797.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nchembio.1797","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nchembio.1797.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T12:06:15Z","timestamp":1691582775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nchembio.1797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,13]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["BFnchembio1797"],"URL":"https:\/\/doi.org\/10.1038\/nchembio.1797","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,13]]},"assertion":[{"value":"6 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}